New drugs: Febuxostat, lacosamide, and rufinamide.
Hussar
Daniel A
DA
Philadelphia College of Pharmacy, University of the Sciences, Philadelphia, USA.
Bilbow
Caitlin
C
D000081:Acetamides / Q000008:administration & dosage* / Q000009:adverse effects / Q000493:pharmacokinetics; D000818:Animals; D000927:Anticonvulsants / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics; D002986:Clinical Trials as Topic; D004827:Epilepsy / Q000188:drug therapy / Q000503:physiopathology; D000069465:Febuxostat; D006073:Gout / Q000188:drug therapy / Q000503:physiopathology; D006074:Gout Suppressants / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics; D006801:Humans; D000078334:Lacosamide; D013844:Thiazoles / Q000008:administration & dosage* / Q000009:adverse effects / Q000493:pharmacokinetics; D014230:Triazoles / Q000008:administration & dosage* / Q000009:adverse effects / Q000493:pharmacokinetics
D000081:Acetamides; D000927:Anticonvulsants; D006074:Gout Suppressants; D013844:Thiazoles; D014230:Triazoles; D000069465:Febuxostat; D000078334:Lacosamide; C079703:rufinamide